~~<i id='9248F2FB9F'><strike id='9248F2FB9F'><tt id='9248F2FB9F'><pre id='9248F2FB9F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

explore

hotspot

author：knowledge 2025-09-02 17:40:16 - browse：31598

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： There should be a 'Moonshot' or 'Warp Speed' for rare diseases

leisure time

hotspot

leisure time

knowledge

explore

AdobeChangeHealthcare’srecentcyberattackhashospitals,doctors’offices,andpharmaciesacrossthecountryre

WSS

Change Healthcare cyberattack shows risk of industry consolidation

Color Health wants to make cancer screenings convenient

Using force crossed my mind when examining a defiant young patient

Pfizer is about to make a big push in cancer. Will investors listen?

Biden has enormous polling lead in Democratic primary, despite challenge from RFK Jr.

5 wounded, 2 critically, in Michigan shopping center shooting

explore

hotspot

leisure time

George Santos makes 1st court appearance after pleading not guilty to 13 counts

5 ways to address the shortage of health care workers

Dobbs anniversary: the lost opportunity of abortion as health care

STAT Madness 2024: Meet the contenders

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Virtual repurposing can help discover new uses for existing drugs

Alkermes shareholders re

'Weather

Sports medicine is finally prioritizing gender equality

Fla. should 'correct' controversial slavery curriculum: Republican Rep. Byron Donalds

hotspot

Readout Newsletter: The latest on Amylyx, Moderna, Novavax

Readout Newsletter: Beam, Prozac, "TechBio" and more

Japan raises alarm over China's military, Russia ties and Taiwan tensions in new defense paper

Ohio train derailment: Experts on toxic chemical risks

Study fuels hope CAR

Change Healthcare cyberattack shows risk of industry consolidation

hotspot

leisure time

knowledge

explore